Details

Autor(en) / Beteiligte

• Silva, Murillo
• Kato, Yu
• Melo, Mariane B
• Phung, Ivy
• Freeman, Brian L
• Li, Zhongming
• Roh, Kangsan
• Van Wijnbergen, Jan W
• Watkins, Hannah
• Enemuo, Chiamaka A
• Hartwell, Brittany L
• Chang, Jason Y H
• Xiao, Shuhao
• Rodrigues, Kristen A
• Cirelli, Kimberly M
• Li, Na
• Haupt, Sonya
• Aung, Aereas
• Cossette, Benjamin
• Abraham, Wuhbet
• Kataria, Swati
• Bastidas, Raiza
• Bhiman, Jinal
• Linde, Caitlyn
• Bloom, Nathaniel I
• Groschel, Bettina
• Georgeson, Erik
• Phelps, Nicole
• Thomas, Ayush
• Bals, Julia
• Carnathan, Diane G
• Lingwood, Daniel
• Burton, Dennis R
• Alter, Galit
• Padera, Timothy P
• Belcher, Angela M
• Schief, William R
• Silvestri, Guido
• Ruprecht, Ruth M
• Crotty, Shane
• Irvine, Darrell J

Titel

A particulate saponin/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immunity

Ist Teil von

• Science immunology, 2021-12, Vol.6 (66), p.eabf1152

Ort / Verlag

United States

Erscheinungsjahr

2021

Quelle

MEDLINE

Beschreibungen/Notizen

• Saponins are potent and safe vaccine adjuvants, but their mechanisms of action remain incompletely understood. Here, we explored the properties of several saponin formulations, including immune-stimulatory complexes (ISCOMs) formed by the self-assembly of saponin and phospholipids in the absence or presence of the Toll-like receptor 4 agonist monophosphoryl lipid A (MPLA). We found that MPLA self-assembles with saponins to form particles physically resembling ISCOMs, which we termed saponin/MPLA nanoparticles (SMNP). Saponin-containing adjuvants exhibited distinctive mechanisms of action, altering lymph flow in a mast cell–dependent manner and promoting antigen entry into draining lymph nodes. SMNP was particularly effective, exhibiting even greater potency than the compositionally related adjuvant AS01 in mice, and primed robust germinal center B cell, T , and HIV tier 2 neutralizing antibodies in nonhuman primates. Together, these findings shed new light on mechanisms by which saponin adjuvants act to promote the immune response and suggest that SMNP may be a promising adjuvant in the setting of HIV, SARS-CoV-2, and other pathogens.